In an effort to identify a promoter suitable for studying early ocular development, we generated transgenic mice carrying the lacZ reporter gene linked to the tyrosinase-related protein 2 (TRP2) promoter. TRP2-lacZ was expressed in early retinal pigment epithelium (RPE) and early neural crest cells in embryos. The promoter activity was robust and consistent in independent transgenic lines. The transgene was also expressed in the optic nerve and neural crest-derived neuronal cells in which the endogenous TRP2 gene is not expressed. This suggests that repressor elements may be missing in the promoter used in this study. To test whether this promoter can be used to study melanocyte development, we cross-mated TRP2-lacZ transgenic mice with mice heterozygous for the Patch (Ph) mutation. The pattern of ␤-galactosidase activity in the embryos correlates well with the pigmentation phenotype in postnatal and adult Ph/؉ mice. We also generated transgenic mice expressing fibroblast growth factor 9 (FGF9) directed by the TRP2 promoter and examined the effect on ocular development. Ectopic expression of FGF9 in the early embryonic RPE switched its differentiation pathway to a neuronal fate, resulting in formation of a duplicated neural retina in transgenic mice. These studies demonstrate that the TRP2 promoter is valuable for transgenic studies of ocular differentiation and development of neural crest cells.
INTRODUCTION
Tyrosinase-related protein 2 (TRP2) is an enzyme involved in an intermediate step of melanin synthesis (Pawelek et al., 1980; Aroca et al., 1990; Tsukamoto et al., 1992) . TRP2 isomerizes DOPAchrome to eumelanin 5,6-dihydroxyindole-5-carboxylic acid. Therefore, TRP2 is also called DOPAchrome tautomerase (DCT) (Aroca et al., 1990) . TRP2 is encoded at the Slaty locus on mouse chromosome 14 . The sequence of TRP2 from Slaty mice shows a single base (and single amino acid) difference from the wild type, located within one of the putative copper binding sites of the protein . This mutation results in three-to fourfold reduction in DCT activity such that the mice produce dark gray/brown rather than black eumelanin. TRP2 expression is detected in pigmented cells in ocular tissues and melanocyte precursors in the mouse embryo (Steel et al., 1992; Pavan and Tilghman, 1994; WehrleHaller and Weston, 1995) .
TRP2 is one of the earliest molecular markers for retinal pigment epithelium (RPE) and melanocyte differentiation. During mouse embryogenesis, TRP2 is first expressed in the optic vesicle at E9.5 (Steel et al., 1992) . The region that expresses this gene is destined to become RPE. The onset of TRP2 expression precedes the invagination of the optic vesicle and morphological expansion of neural epithelial cells in the optic vesicle. This suggests that the TRP2 promoter may be used to target transgene expression to RPE at the very beginning of ocular differentiation. TRP2 expression can be detected in melanocyte precursors in E10.5 mouse embryos, 6 days before melanin synthesis begins (Steel et al., 1992; Cable et al., 1995) . Therefore, the TRP2 promoter may also be useful for studying early development of melanocytes.
To test these possibilities, we generated transgenic mice carrying a lacZ gene linked to either a 3.7-or a 1.7-kb mouse TRP2 promoter. The expression patterns of the TRP2-lacZ transgenes were visualized by assay for ␤-galactosidase (␤-gal) activity and were compared to the endogenous TRP2 gene assayed by in situ hybridization with an antisense riboprobe. The robustness and consistency of transgenic TRP2 promoter activity in ocular and neural crest-derived tissues suggest that it may be a useful tool for targeting transgene expression to these tissues. To determine whether TRP2-lacZ transgenic mice can be used to study melanocyte development, they were mated with mice heterozygous for the Patch (Ph) mutation. The pattern of ␤-gal-positive melanocyte precursors in the embryos was consistent with the pigmentation phenotype in postnatal and adult Ph/ϩ mice.
To test whether the TRP2 promoter can be used to express secreted signaling proteins to influence ocular development, we generated transgenic mice expressing fibroblast growth factor 9 (FGF9) directed by this promoter. Ectopic expression of FGF9 in the early embryonic RPE switched its differentiation pathway to a neuronal fate, resulting in formation of a second layer of neural retina in the transgenic mice. These experiments demonstrate that the TRP2 promoter can be used for transgenic studies of ocular differentiation and development of neural crest cells.
METHODS

Generation and Screening of Transgenic Mice
A 3.7-kb genomic fragment (Ϫ3290 to ϩ443 relative to the transcription initiation site) from the mouse TRP2 gene (provided by Drs. P. Budd and I. Jackson) (Budd and Jackson, 1995) was excised from the vector with restriction endonucleases StuI and PstI and used to replace the mouse heat-shock promoter (hsp68) in the hsp-lacZ-SV40 pA vector (provided by Dr. J. Rossant) (Kothary et al., 1989) . The hsp68 promoter was removed by digestion with BstEII (blunt-ended) and PstI. The DNA fragment for microinjection was released by digestion with BamHI or SphI and BamHI, yielding 7.4-and 5.4-kb fragments, respectively (Fig. 1A) . These two fragments, containing either the 3.7-or the 1.7-kb promoter, were separated from the vector backbone by gel electrophoresis and purified with the Qiaex II DNA purification kit (Qiagen). Both fragments were injected into one-cell-stage embryos from FVB/N mice to generate transgenic mice as previously described (Taketo et al., 1991) . Potential founder mice were screened by polymerase chain reaction (PCR) with genomic DNA extracted from mouse tails (Robinson et al., 1995) . The PCR primers flank a 240-bp fragment in the lacZ gene (sense, 5Ј-TGG CTG GAG TGC GAT CTT CCT GAG-3Ј; antisense, 5Ј-GCC GAG TTA ACG CCA TCA AAA ATA-3Ј) (Yokoyama et al., 1992) . PCR was carried out for 30 cycles using the following conditions: denaturation at 94°C for 30 s, annealing at 60°C for 1 min, and elongation at 72°C for 1 min.
To facilitate preparation of DNA constructs using the TRP2 promoter, we made a vector with multiple cloning sites flanked upstream by the 1.7-kb TRP2 promoter and downstream by the 0.8-kb SV40 small t intron and polyadenylation sequences (SV40 int-pA) (Lovicu and Overbeek, 1998) . A 0.9-kb cDNA encoding mouse FGF9 (provided by Dr. D. Ornitz) was inserted into the ClaI and EcoRI sites of the vector to give rise to the TRP2-FGF9 construct (Fig. 1B) . The injection fragment was released by digestion with KpnI and NotI. Potential transgenic mice were again screened by PCR using primers flanking a 0.3-kb fragment from the SV40 int-pA (sense, 5Ј-GTG AAG GAA CCT TAC TTC TGT GGT G-3Ј; antisense, 5Ј-GTC CTT GGG GTC TTC TAC CTT TCT C-3Ј) (Lovicu and Overbeek, 1998) .
FIG. 1. TRP2-lacZ (A)
and TRP2-FGF9 (B) DNA constructs. For making the TRP2-lacZ construct, a 3.7-kb TRP2 promoter was inserted into a vector with the lacZ gene and SV40 polyadenylation sequences (SV40 pA). The construct was digested with either BamHI or SphI and BamHI, yielding 7.4-and 5.4-kb fragments for microinjection. For the TRP2-FGF9 construct, a 0.9-kb FGF9 cDNA was inserted into ClaI and EcoRI sites of a vector containing the 1.7-kb TRP2 promoter and SV40 small t intron and polyadenylation sequences (SV40 int-pA). The 3.5-kb microinjection fragment was obtained by digestion with KpnI and NotI. between the neural retina and RPE but not in the optic stalk or periocular mesenchyme (F). In the E14.5 eye, TRP2-lacZ (G) was expressed in the RPE, presumptive iris, and ciliary epithelia. Many melanocyte precursors were present in the eyelid (EL). The endogenous gene was expressed in the RPE, eyelid, and neural crest cells in periocular mesenchyme (H). The labeled neural crest cells near the RPE may be choroid precursors. Abbreviations: C, cornea; D-V, dorsal-ventral orientation; L, lens; LP, lens pit; LV, lens vesicle; NR, neural retina; SE, surface ectoderm. Scale bars, 50 m (A, C), 100 m (E), and 200 m (G).
FIG. 3.
Expression of TRP2-lacZ (A, C, E, and G) and endogenous TRP2 (B, D, F, and H) in the embryonic eye. The red staining in the in situ hybridization sections (B, D, F, and H) indicates hybridized 35 S-labeled antisense riboprobe. At E9.5, both the transgene (A) and the endogenous gene (B) were expressed in the dorsal optic vesicle (OV). At E10.5, TRP2-lacZ (C) was expressed in the outer layer of the optic cup (RPE) and in the optic stalk (OS) while the endogenous gene (D) was expressed only in the presumptive RPE. In the E11.5 eye, transgene expression (E) was present in the RPE, the optic stalk, and the anterior margin (AM) of the retina, which will give rise to the iris and ciliary epithelia. Blue presumptive neural crest cells (NC) were seen migrating into the periocular region. Endogenous TRP2 was expressed in the RPE and anterior margin
FIG. 4. Expression of TRP2-lacZ (A, B, C, and E) and endogenous TRP2 (D and F) in nonocular tissues.
A transverse section of E11.5 embryonic brain (A) showed that TRP2 promoter activity was present in distal regions of the telencephalic ventricle (TV) and in putative neural crest cells (arrows). At this stage, many ␤-gal-positive cells with morphology of neural crest cells had migrated into the regions near the otic vesicle (OT) (B). Transverse sections of the posterior embryo at E11.5 (C) showed that TRP2-lacZ was expressed in both dorsolaterally migrating putative melanocyte precursors (MC) and ventrally migrating neural crest cells which have given rise to a variety of cells including dorsal root ganglia (DRG), sympathetic ganglia (SG), and ventral root Schwann cells (SC). The endogenous TRP2 gene was expressed in only a few melanocyte precursors (D). Sections of E14.5 embryonic heads showed that both the transgene (E) and the endogenous gene (F) were expressed in melanocyte precursors underneath epidermal epithelium (EE) and in whisker follicles (WF or arrows in F). Abbreviations: 3rd V, third ventricle; HV, primary head vein; MDA, midline dorsal aorta; ML, motor neuron layer; NCD, notochord; NT, neural tube. Scale bars, 100 m.
Staining for ␤ -Gal Activity
To examine the pattern of TRP2-lacZ transgene expression, transgenic mice were set up to mate with wild-type FVB/N or Ph/ϩ partners (obtained from The Jackson Laboratory). Timed-pregnant female mice or postnatal mice were sacrificed at various stages. Mouse embryos or eyes were collected and subject to X-Gal (5-bromo-4-chloro-3-indolyl ␤-D-galactoside) staining for ␤-gal activity as previously described (Langford et al., 1991) . Mouse tissues were fixed in 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.3) at 4°C for 1 h. After three 30-min rinses (in 0.01% sodium deoxycholate, 0.02% NP-40, 2 mM MgCl 2 , and 0.1 M phosphate buffer, pH 7.3), ␤-gal activity was visualized in X-Gal staining solution (0.1 M phosphate buffer, pH 7.3, 2 mM MgCl 2 , 0.01% sodium deoxycholate, 0.02% NP-40, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 1 mg/ml X-Gal). Tissues were stained in X-Gal solution at 4°C for 4 to 12 h. Stained tissues were rinsed in phosphate-buffered saline (pH 7.4) and then stored in 70% ethanol. Heterozygous Ph embryos were identified by their melanocyte phenotype as previously reported (WehrleHaller et al., 1996) . After examination and photography of the overall pattern of transgene expression in the embryo or eye, the tissues were processed in ethanol and Histo-Clear (National Diagnostics) and then embedded in paraffin for sectioning. Tissue sections were counterstained with Nuclear Fast Red (Poly Scientific).
In Situ Hybridization
To determine the expression pattern of endogenous TRP2, we carried out in situ hybridization using an 35 S-labeled antisense RNA probe as previously described (Robinson et al., 1995) . Briefly, the TRP2 plasmid containing the first few hundred bases of transcribed sequences (Budd and Jackson, 1995) was linearized by digestion with restriction endonuclease PmlI. An antisense RNA probe was synthesized using T3 RNA polymerase in the presence of [
35 S]UTP. Tissue sections were incubated with hybridization solution containing the RNA probe. After washes, RNase treatment, and dehydration, the slides were coated with Kodak NTB-2 emulsion for autoradiography. The slides were developed and mounted with a coverslip and then examined for silver grain distribution under dark-field illumination. Both the bright-and the dark-field images were collected by computer through a CCD camera (Leica) and subsequently superimposed onto each other using PhotoShop software (Adobe). Silver grains in the dark-field images were pseudo-colored red to improve contrast in the superimposed images.
Immunohistochemistry
Mouse eyes were collected on postnatal day 6 (P6) and fixed in 10% formalin overnight at room temperature and then rinsed in 70% ethanol for 24 h. The eyes were next dehydrated using ethanol solutions of increasing concentration, cleared in xylene, and embedded in paraffin wax. Sections were cut on a microtome, dewaxed with xylene, and rehydrated using decreasing concentrations of ethanol. Tissue sections were incubated with 5% normal goat serum in phosphate-buffered saline (PBS) at room temperature for 15 min to block nonspecific antibody binding. The tissue sections were then incubated with a monoclonal antibody to rhodopsin (Barnstable, 1980) at 4°C overnight. After being rinsed with PBS, the tissue sections were incubated with fluorescein-labeled antimouse IgG (Sigma) at room temperature for 1 h. The slides were then rinsed with PBS and coverslipped in 50% glycerol in PBS for examination under blue-light illumination. After fluorescent images were captured using a CCD camera, the tissue sections were stained with hematoxylin/eosin for histological examination.
RESULTS
Expression of the TRP2-lacZ Transgene
Six transgenic founder mice were obtained with the 7.4-kb TRP2-lacZ construct. Two of them did not express the transgene and were discarded. Four transgenic founder mice were generated with the 5.4-kb TRP2-lacZ fragment and they all expressed the transgene. All expressing transgenic lines showed similar patterns of transgene expression.
TRP2-lacZ transgene expression was first detected at embryonic day 9.5 (E9.5) in the dorsal region of the optic vesicle ( Figs. 2A and 3A) . The expression extended to the entire presumptive RPE by E10.5 (Figs. 2B and 3C ). At this stage, TRP2-lacZ started to be expressed in the forebrain and in migrating individual cells resembling neural crest cells (NC). E12.5 embryos expressed the transgene in the eye, the forebrain, certain regions of the midbrain (arrowheads), and many neural crest-derived cells lateral to the neural tube (Fig. 2C) . Dorsal root ganglia (DRG) positive for ␤-gal activity were present in the posterior region of the embryo (Figs. 2C and 4C ). In E14.5 embryos, in addition to the eye and forebrain, ␤-gal-positive cells were seen across nearly the entire embryo and were particularly prominent in the eyelid (EL), outer ear, hindlimb, tail, and whisker follicles (WF) (Fig. 2D) . Based on the morphology of the positive cells, their pattern of interspersion within the mesenchyme, and their localized accumulation within the embryo (Figs.4B, 4C , and 4E), most of these cells appear to be neural crest derived.
Histological sections were prepared to compare patterns of transgene expression (Figs.3A, 3C , 3E, and 3G) to those of endogenous TRP2 expression (Figs. 3B, 3D , 3F, and 3H) in embryonic eyes. At E9.5, expression of the TRP2-lacZ transgene was present in the dorsal optic vesicle (Fig. 3A) , analogous to that of endogenous TRP2 (Fig. 3B) . In the optic cup of E10.5 embryos, the transgene was expressed in the presumptive RPE and in the optic stalk (Fig. 2C) . However, endogenous TRP2 was expressed only in the presumptive RPE but not in the optic stalk (Fig. 3D) . Similar disparities between the transgene and the endogenous gene were also observed at later stages. In E11.5 eyes, TRP2-lacZ activity was present in the RPE, the optic stalk, and the cells of the anterior margin between neural retina and RPE, which will give rise to the iris and ciliary epithelia (Fig. 3E) . Many ␤-gal-positive cells that appear to be NC derived were present in the periocular mesenchyme. In contrast, the endogenous TRP2 gene was expressed only in the RPE and the anterior margin between neural retina and RPE but not in the optic stalk or mesenchyme (Fig. 3F) . In E14.5 eyes, the transgene was expressed in the RPE, the presumptive iris and ciliary epithelia, and a subset of mesenchymal cells in the EL (Fig. 3G) . Endogenous TRP2 was expressed in the same cells and also in the periocular mesenchyme (Fig. 3H) . The weak staining of RPE and lack of staining in periocular mesenchyme of the transgenic embryo (Fig. 3G) were likely due to limited penetration of the X-gal staining solution into the embryo.
Outside the eye of E11.5 embryos, expression of the TRP2-lacZ transgene in the distal region of the telencephalic vesicle (Fig. 4A ) and in tissues near the otic vesicle (Fig. 4B) is consistent with endogenous TRP2 expression reported previously (Steel et al., 1992) . In addition to its expression in dorsolaterally migrating cells (putative melanocyte precursors), TRP2-lacZ expression was detected in ventrally migrating neural crest cells including cells in the DRG, sympathetic ganglia (SG), and ventral root Schwann cells (SC) (Fig. 4C) (Weston, 1963; Lumsden, 1988) . Transgene expression in dorsal root ganglia along the posterior neural tube was especially prominent (Figs. 2C and 4C) . The endogenous TRP2 gene, however, was expressed only in a few dorsolaterally migrating melanocyte precursors (Fig.  4D) . No endogenous TRP2 expression was detected in other neural crest-derived cells such as DRG, SG, or SC. In E14.5 embryos (Figs. 2D and 4E ), TRP2-lacZ expression was present in melanocyte precursors underneath epidermal epithelium and in developing WF (Fig. 4E ). This pattern of expression was consistent with that of endogenous TRP2 (Fig. 4F) .
At P3, TRP2-lacZ was expressed in many regions of the eye including the optic nerve (Fig. 5A) . A section of the eye showed strong expression in the RPE, the pigmented layer of the ciliary epithelium, iris, choroid, and optic nerve (Figs.  5B-5D ). In the ciliary body, TRP2 promoter was not active in the unpigmented ciliary epithelium (Fig. 5D) . The pattern of endogenous TRP2 expression (Figs. 5E and 5F) was similar to that of the TRP2-lacZ transgene except that the endogenous gene was not expressed in the optic nerve. This is consistent with the observation in embryos that the TRP2-lacZ transgene but not endogenous TRP2 was expressed in the optic stalk (Fig. 3) . In addition, corneal endothelial cells appeared to weakly express the TRP2-lacZ transgene (Fig. 5D ) while they did not express the endogenous TRP2 gene (Figs. 5E and 5F ). In adult eyes, expression patterns of the transgene and endogenous gene were essentially identical to those in P3 eyes (data not shown).
Expression of TRP2-lacZ in Ph/ ؉ Embryos
The Ph mutation results in a dominant white spotting phenotype characterized by a depigmented belt around the abdomen (Gruneberg and Truslove, 1960; Searle and Truslove, 1970) . The Ph mutation is a genomic deletion that includes the entire gene encoding the platelet-derived growth factor receptor ␣ subunit (Pdgfra) (Stephenson et al., 1991; Smith et al., 1991) . Ph/Ph homozygous embryos display multiple defects (including small size and abnormalities in the somites, heart, and neural tube) and die around midgestation (Gruneberg and Truslove, 1960; Morrison-Graham et al., 1992; Schatteman et al., 1992; Orr-Urtreger et al., 1992) .
To test whether the TRP2-lacZ transgenic mice can be used to study alterations in melanocyte development, these mice were mated with Ph/ϩ mice. In E14.5 TRP2-lacZ transgenic embryos with no Ph mutation, ␤-galϩ melanocyte precursors were spread over nearly the entire embryo (Figs. 2D and 6A) . However, in Ph/ϩ embryos, the number of ␤-galϩ cells was significantly reduced, even in regions such as the outer ear, the eyelid, and the tail (Fig. 6B) . This phenotype was particularly prominent in the middle trunk of the embryo. The apparent absence of melanocyte precursors in this region correlates well with the depigmentation phenotype in the postnatal and adult Ph/ϩ mice. The thin blue stripes in ϩ/ϩ and Ph/ϩ embryos may be neural crest-derived sympathetic neurons or glia (arrows in Figs. 6A and 6B).
Ectopic Neural Retina in TRP2-FGF9 Transgenic Mice
The TRP2-FGF9 construct was injected into one-cellstage embryos and some of the recipient females were sacrificed after 15 days of gestation. Nine potential transgenic embryos were collected. PCR assays using primers specific to the SV40 int-pA sequences identified two embryos carrying the TRP2-FGF9 transgene. In one of the embryos, the ocular morphology appeared normal. Subsequent in situ hybridization using an antisense RNA probe to SV40 pA showed that the TRP2-FGF9 transgene was not expressed in this embryo (data not shown). In the other embryo, a striking abnormality occurred in the eyes. The presumptive RPE was converted to a second layer of neural retina (Fig. 7A) . In the eyes of the wild-type littermates, RPE was a monolayer of epithelial cells (Fig. 7B) .
Among the injected embryos that were allowed to develop to term, one fertile transgenic male with small eyes was obtained and mated with a C57BL/6 female. In the eyes of the transgenic offspring at postnatal day 6, cells in both the endogenous neural retina and the RPE-derived neural retina had differentiated and laminated to form three distinct cell layers, the photoreceptor layer, the intermediate nuclear layer, and the ganglion cell layer (Fig. 7C) . Plexiform layers (red and black arrows) can be seen in the endogenous and the duplicated neural retinae. Immunohistochemical labeling using an antibody to rhodopsin (Barnstable, 1980; Zhao and Barnstable, 1996) revealed that cells on each side of the ventricular zone had differentiated into photoreceptors (Fig. 7D ). This result indicates that FGF signaling can influence tissue specification during ocular development and provides a definitive proof that the early embryonic RPE can be genetically reprogrammed to become neural retina in vivo.
DISCUSSION
Expression Patterns of the TRP2 -lacZ and Endogenous TRP2
Among the 10 transgenic lines generated with either the 3.7-or 1.7-kb TRP2 promoter, 8 expressed the transgene and all showed similar patterns of expression. This indicates that the tissue specificity of transgene expression is intrinsic to the TRP2 promoter and independent of the site of transgene integration in the genome. In addition, the 1.7-kb promoter appears to contain the essential regulatory elements for the tissue specificity. MacKenzie et al. (1997) have previously reported use of a 3.6-kb TRP2 promoter to direct lacZ expression in transgenic mice and to study melanocyte development in c-Kit mutant embryos. Their pattern of lacZ transgene expression is similar to that observed in our transgenic embryos, confirming the consistency of TRP2 promoter activity.
The present and previous studies (Steel et al., 1992; Pavan and Tilghman, 1994; Wehrle-Haller and Weston, 1995; MacKenzie et al., 1997) have demonstrated that endogenous TRP2 expression and transgenic TRP2 promoter activity are restricted to specific tissues derived from neuroectoderm and neural crest. The TRP2-lacZ transgene is consistently expressed in certain ocular and neural crestderived tissues that do not normally express endogenous TRP2. These tissues include the optic stalk (or optic nerve at later stages), dorsal root ganglia, sympathetic ganglia, and ventral root Schwann cells (Figs. 3-5 ). These observations suggest that endogenous TRP2 expression may normally be repressed in these tissues and that one or more repressor elements may be missing in the 1.7-and 3.7-kb TRP2 promoters.
It is intriguing that both endogenous TRP2 and TRP2-lacZ genes are expressed in the developing forebrain. Recently, tyrosinase has also been shown to be present in both mouse and human brain (Tief et al., 1996a (Tief et al., ,b, 1997 (Tief et al., , 1998 Xu et al., 1997) . Tyrosinase-related protein 1 (TRP1) promoter
FIG. 5. Expression of TRP2-lacZ by X-Gal staining (A-D)
and expression of endogenous TRP2 by in situ hybridization with an antisense riboprobe (E and F) in P3 eyes. An X-Gal-stained P3 eye (A) showed widespread transgene expression in ocular tissues including the optic nerve (ON). A section of the eye (B-D) showed that the transgene was strongly expressed in the RPE, presumptive pigmented ciliary epithelium (PCE), iris (Ir), choroid (Ch), optic nerve, astrocytes (AC) migrating onto the vitreoretinal surface, and also weakly in the peripheral corneal endothelium (CE). Highmagnification images of box 1 and box 2 in (B) are shown in (C) and (D), respectively. Expression of endogenous TRP2 (E) in the eye was nearly identical to that of TRP2-lacZ (B) except in the optic nerve and corneal endothelium which did not express the endogenous gene (E and F). A high-magnification image of the boxed region in (E) is shown in (F). The pattern of silver grain labeling (black grains in F) in the iris and ciliary body is the same as ␤-gal staining in the transgenic mouse (D). Abbreviations: C, cornea; HV, hyaloid vessels; NR, neural retina; P, pupil; Sc, sclera; UCE, unpigmented ciliary epithelium. Scale bars, 50 m (C, D), 100 m (F), 200 m (A, B, E).
FIG. 6.
X-Gal staining of ϩ/ϩ and Ph/ϩ TRP2-lacZ transgenic embryos at E14.5 (A, B). ␤-Gal-positive cells were widely spread across embryos with no Ph mutation (A). In Ph/ϩ embryos, there were significantly fewer melanocyte precursors (B). The lack of blue melanocyte precursors was particularly prominent in the middle region of the trunk. The positive thin blue stripes may be neural crest-derived parasympathetic neurons or glia (arrows in A and B). Abbreviations: EL, eyelid; FB, forebrain; OE, outer ear; T, tail; WF, whisker follicles.
activity was also observed in many regions of the mouse brain (Tief et al., 1998) . The present study adds to the increasing evidence that members of the tyrosinase protein family may play important roles in the nervous system.
Melanocyte Precursors in Ph/؉ Embryos
There is a cluster of closely linked coat-color mutations in the central portion of mouse chromosome 5, including dominant white spotting (W), Ph, and rump white (Rw) (Searle and Truslove, 1970) . Various alleles of W disrupt the structure or expression of the c-Kit receptor tyrosine kinase (Geissler et al., 1988; Duttlinger et al., 1993; Nocka et al., 1990) . The function of c-Kit is essential for development of many cell types including primordial germ cells, hematopoietic cells, and melanocytes (Reith et al., 1990; Huizinga et al., 1995) . The Ph mutation is a deletion encompassing the entire coding region of another tyrosine kinase receptor gene, Pdgfra (Stephenson et al., 1991; Smith et al., 1991; Nagle et al., 1994) . However, the pigmentation defect in Ph/ϩ mice cannot be attributed to haploinsufficiency of PDGFR␣ because mice heterozygous for a targeted Pdgfra null mutation do not display a pigmentation defect (Soriano, 1997) . Several studies have suggested that the Ph deletion alters long-range cis-regulatory elements for the c-Kit gene and results in misexpression of c-Kit and, therefore, an abnormal pattern of pigmentation (Duttlinger et al., 1995; Wehrle-Haller et al., 1996; Kluppel et al., 1997) . Analysis of melanocyte development in mouse embryos with Steel, Ph, and W mutations indicates that signaling through the c-Kit receptor is required for survival and perhaps dispersal of melanoblasts (Steel et al., 1992; Pavan and Tilghman, 1994; Cable et al., 1995; Wehrle-Haller and Weston, 1995; Wehrle-Haller et al., 1996; MacKenzie et al., 1997) . Steel encodes the ligand for c-Kit. A more recent study showed that the Rw mutation also causes misexpression of c-Kit (Hough et al., 1998) .
In previous studies of melanocyte development in these mutant mice, expression of the endogenous TRP2 was used as the marker for melanocyte precursors. These precursor cells were identified by in situ hybridization with antisense riboprobes on either tissue sections (Steel et al., 1992; Cable et al., 1995) or whole-mount embryos (Wehrle-Haller and Weston, 1995; Wehrle-Haller et al., 1996) . The present study and the earlier report by MacKenzie et al. (1997) suggest that TRP2-lacZ transgene expression can be used as a marker for early melanocyte precursors and for studying melanocyte development in mice with mutations such as Ph. Visualization of melanocyte precursors by X-Gal staining of mouse embryos is much more convenient and sensitive than in situ hybridization with riboprobes. A previous study by Wehrle-Haller et al. (1996) found that melanocyte precursors expressing TRP2 were present along the dorsal midline of Ph mutant embryos at E11.5. Our study indicates that by E14.5 these cells have disappeared and have not migrated elsewhere (see Fig. 6B ). Our data support the notion that many melanocyte precursors fail to survive on FIG. 7. Hematoxylin/eosin staining of eye sections from TRP2-FGF9 transgenic and nontransgenic embryos (A, B), and fluorescent labeling of a P6 eye section using a rhodopsin antibody (D) followed by hematoxylin/eosin staining (C). In an E15.5 TRP2-FGF9 transgenic (TG) embryo (A), the RPE was converted to a second layer of neural retina (rNR) while in its nontransgenic (NTG) littermate, the RPE was a monolayer of epithelial cells (B). In TRP2-FGF9 transgenic mice at P6, a high-magnification view of the posterior region of the eye (C) shows that three neuronal cell layers have formed in both the endogenous neural retina (NR) and the rNR. One plexiform layer (red arrows) separates the ganglion cell layer (G) and the intermediate nuclear layer (I) while another plexiform layer (black arrows) is beginning to form between the intermediate nuclear layer and the photoreceptor layer (P). The pigmented tissue adjacent to the ganglion cell layer in the rNR is choroid (green arrowhead). Immunofluorescent labeling with an antibody to rhodopsin indicates that photoreceptor cells were generated along the ventricular boundary (blue arrows) of both retinae (D). Autofluorescence was detected from striated muscle (black arrowhead in C and white arrowhead in D). Abbreviations: C, cornea; L, lens. Scale bars, 50 m (D) and 100 m (A, B) .
the Ph/ϩ background although it is possible that these cells are still alive but have stopped expressing TRP2 due to the absence of a signal required for their normal differentiation.
Targeting Ocular Tissue with the TRP2 Promoter
In vertebrates, the optic vesicle grows out of the diencephalon during early ocular genesis. As the distal portion of the optic vesicle contacts the surface ectoderm, it starts to invaginate to form a two-layer structure termed the optic cup (Morse and McCann, 1984) . The inner layer becomes the neural retina while the outer layer becomes the RPE. The anterior margin between these two layers subsequently gives rise to the iris and ciliary epithelia (Barnstable, 1991) . It is believed that the early optic vesicle neuroepithelium has equal potential to become either neural retina or RPE. It is still not known when and how different regions of the optic vesicle become committed to a specific differentiation pathway.
It has been previously shown that early embryonic chick RPE can transdifferentiate to neural tissue when exposed to FGF1 or FGF2 in vivo Hollenberg, 1989, 1991; Hyer et al., 1998) or in vitro (Pittack et al., 1991; Guillemot and Cepko, 1992) . It has also been shown that the mammalian embryonic RPE is able to transdifferentiate to neural retina in vitro when stimulated by FGF2 (Zhao et al., 1995 (Zhao et al., , 1997 . In the present study, we demonstrate that ectopic expression of FGF9 using the TRP2 promoter converts the embryonic RPE from a monolayered cuboidal epithelium to a second neural retina (Figs. 7A, 7C , and 7D). The second neural retina forms three distinct cell layers including photoreceptors, implying that the presence of an RPE is not required for cell fate determination in the neural retina. Our results provide further evidence that secreted molecules such as FGFs may be involved in tissue specification and differentiation during ocular development (Robinson et al., 1995; Zhao et al., 1997; Lovicu and Overbeek, 1998) .
In summary, we show in this study that the TRP2 promoter can be used to target transgene expression to certain subsets of neural crest cells and to retinal pigment epithelial cells during mouse development. The robustness, consistency and early onset of TRP2 promoter activity make it a promising tool to manipulate early ocular development and differentiation of neural crest cells. The feasibility of such studies has been demonstrated by use of the TRP2-lacZ transgenic mice to examine melanocyte development in mouse embryos with the Ph mutation and by targeting FGF9 expression to the early RPE thereby converting it to neural retina.
